GPNX
NOTIFICATION PROCESSED BY IB
12/20/2022
Back to search
Official data from USPTO
VOYTISTE
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: US
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
16
Latest update
12/20/2022
Classification
Registered
Trademark type
Word
Nice classes
5
Filing date
09/28/2021
Registration date
10/18/2022
Expiration date
-
Recommended action
Perform a full collision analysis and validate classes before any filing or trademark investment.
Next step
These are the details of the registration process. Even so, constant monitoring is what ensures peace of mind that your main asset remains protected.
Complete case details
Structured fields from the responsible authority and the official record.
Status date
10/18/2022
Last transaction
10/18/2022
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Drawing code
4
Owner type
99
Owner location
DE
Examiner
MCDOWELL, MATTHEW J
Law office
L10
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
Boehringer Ingelheim International GmbH
Representatives
Boehringer Ingelheim Corporate Center GmbH
Technical classification
Nice Classes
Class 5
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Pharmaceutical preparations for the prevention and treatment of diseases and disorders of the alimentary tract and metabolism, and of the blood and blood forming organs; pharmaceutical preparations for the prevention and treatment of diseases and disorders of the cardiovascular system, musculoskeletal system, central nervous system, peripheral nervous system, genitourinary system and respiratory system; pharmaceutical preparations for the prevention and treatment of dermatological diseases and disorders, damaged skin and tissues; pharmaceutical preparations for the prevention and treatment of inflammation and inflammatory diseases and disorders; pharmaceutical preparations for the prevention and treatment of ophthalmological diseases and disorders; pharmaceutical preparations for the treatment and prevention of hormonal diseases and disorders; pharmaceutical preparations for the treatment and prevention of infectious diseases and disorders and viral infections; pharmaceutical preparations for the prevention and treatment of oncological and auto-immune diseases and disorders; pharmaceutical preparations, namely, cell-based immune therapeutics for treatment of cancer, treatment of immunological diseases, and treatment of infectious diseases
Publications
History of USPTO decisions and trademark events.
16 publications found
FICS
FINAL DISPOSITION NOTICE SENT TO IB
11/30/2022
FIMP
FINAL DISPOSITION PROCESSED
11/30/2022
GPAR
GRANT OF PROTECTION CREATED, TO BE SENT TO IB
11/17/2022
R.PR
REGISTERED-PRINCIPAL REGISTER
10/18/2022
GPNX
NOTIFICATION PROCESSED BY IB
08/02/2022
PUBO
PUBLISHED FOR OPPOSITION
08/02/2022
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
07/13/2022
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
07/13/2022
NPUB
NOTICE OF PUBLICATION
07/13/2022
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
06/28/2022
DOCK
ASSIGNED TO EXAMINER
06/28/2022
MAFR
APPLICATION FILING RECEIPT MAILED
01/25/2022
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
01/21/2022
LIMI
LIMITATION FROM ORIGINAL APPLICATION ENTERED
01/20/2022
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
01/13/2022
Continuous trademark protection
Get notified about every new filing that threatens VOYTISTE or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.